Skip to main content
Smart Investors Daily
HS

NASDAQ · HSCS

HeartSciences Inc.

Healthcare · Medical - Devices

$3.10

Up+$0.15 (+5.08%)

Updated Nov 5, 2026, 3:36 AM

SID Score

3.8/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
5.97M
P/E ratio
-0
Dividend yield
0.00%
52-week range
$1.63 – $5.25
Volume
100.69K
Avg. volume
52.92K

Price performance · HSCS

HSCS price history

1M range · 0 trading sessions · Daily adjusted prices

HSCS does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest HSCS news

The latest Smart Investors Daily articles mentioning HSCS.

HSCS research

Overview

Company profile and research snapshot.

Company profile

HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$3.00
Implied upside
—
Analysts
—
HSCS recent ratings
DateFirmRatingTarget
Mar 24, 2026Ascendiant CapitalBuy—
Dec 22, 2025Ascendiant CapitalBuy—
Oct 1, 2025Ascendiant CapitalBuy—
Mar 18, 2025Ascendiant CapitalBuy—
Dec 18, 2024Maxim GroupBuy—
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.